Is Psilocybin Spores Legal in Brazil After the 2026 Framework Overhaul?

No, psilocybin spores are classified as illegal substances under Brazilian law due to their potential for psychoactive use, despite not containing the active compound. The National Health Surveillance Agency (ANVISA) regulates controlled substances, and spores are treated as precursors under Resolution RDC 344/2002, prohibiting their cultivation or distribution without authorization.

Key Regulations for Psilocybin Spores in Brazil

  • ANVISA’s Controlled Substances List (Portaria SVS/MS 344/1998): Psilocybin and its derivatives are Schedule F1 substances, with spores considered illegal due to their potential to produce psychoactive effects.
  • Federal Law 11.343/2006 (Drug Law): Criminalizes possession, cultivation, or trafficking of substances listed in ANVISA’s schedules, including psilocybin spores, with penalties ranging from 5 to 15 years imprisonment.
  • 2026 Compliance Shifts: ANVISA’s upcoming 2026 review of controlled substances may reclassify psilocybin for medical research, but spores remain prohibited under current interpretations of precursor regulations.

Local enforcement prioritizes interdiction of cultivation, with judicial precedents (e.g., STJ HC 667.421/SP) upholding strict penalties. Research exceptions require ANVISA’s prior approval under RDC 38/2012, which does not extend to spores.